Italian Angels for Biotech
VC Fund
Italian Angels for Biotech is a VC fund focused on Health Care and Biotechnology. Angel group focuses on biotech
- Total investments:
- 5
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Italian Angels for Biotech invests in
Stages Italian Angels for Biotech invests in
Countries Italian Angels for Biotech invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Seed
- $545k–$2M
Investment Focus
Industry
- Health Care 3 (60%)
- Biotechnology 2 (40%)
- Pharmaceutical 2 (40%)
- Manufacturing 1 (20%)
- Medical Device 1 (20%)
Stage
- Seed 3 (60%)
- Pre-Seed 1 (20%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Elena Lanati
VP
|
VP | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
MgShell
|
MgShell offers intraocular devices for the treatment of age-related macular degeneration and other ocular diseases. Their technology is the only technical solution capable of replicating current clinical practice with a single injection and releasing the same therapeutic drug doses at predetermined periods, autonomously and without surgicalprocedures. | $1.3M / Seed / Apr 30, 2025 | |
CaSRevolution
|
CaSRevolution provides pharmaceutical services. They are in the fields of biotech, neurodegeneration, startups, and Alzheimer's. They provided a progression of Alzheimer’s disease and identified a potential therapeutic approach. | $2M / Seed / May 25, 2023 | |
|
CaSRevolution
|
CaSRevolution provides pharmaceutical services. They are in the fields of biotech, neurodegeneration, startups, and Alzheimer's. They provided a progression of Alzheimer’s disease and identified a potential therapeutic approach. | $874.1K / Pre-Seed / May 25, 2023 | |
|
MgShell
|
MgShell offers intraocular devices for the treatment of age-related macular degeneration and other ocular diseases. Their technology is the only technical solution capable of replicating current clinical practice with a single injection and releasing the same therapeutic drug doses at predetermined periods, autonomously and without surgicalprocedures. | $544.7K / Seed / Jan 26, 2023 | |
Metis Precision Medicine
|
Metis Precision Medicine is a B-Corp founded with the vision of bringing powerful cancer therapies to patients in need. Metis owns the intellectual property of a suite of anti-Met monoclonal antibodies (mAbs), with different and unique mechanisms of action, and is currently seeking investors, biotech or pharmaceutical companies interested inacquiring the relevant platform technology on a global basis. | $878K / Seed / Dec 20, 2018 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Italian Angels for Biotech invest in?
Italian Angels for Biotech invests primarily in Health Care, Biotechnology and Pharmaceutical startups, most often at Seed and Pre-Seed stage. Most of the 5 investments tracked by Shizune back companies in Italy. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Italian Angels for Biotech's check size?
Italian Angels for Biotech typically joins rounds of $545k–$2M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Italian Angels for Biotech participates in.
How do I contact Italian Angels for Biotech?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Italian Angels for Biotech?
The team at Italian Angels for Biotech includes Elena Lanati (VP). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
